Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
pcgCDyEDUESFpsAc